Medibank Private Limited (ASX:MPL)
Australia
· Delayed Price · Currency is AUD 4.290
-0.030 (-0.69%)
At close: Mar 6, 2026
Medibank Private Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Premiums & Annuity Revenue | 8,194 | 8,012 | 7,623 | 7,086 | 6,881 | 6,691 | Upgrade
|
| Total Interest & Dividend Income | 158.6 | 176.1 | 164.3 | 108.2 | 55.9 | 51 | Upgrade
|
| Gain (Loss) on Sale of Investments | 32.4 | 33.8 | 19.5 | 30.4 | -80.7 | 69 | Upgrade
|
| Other Revenue | 385.3 | 334.7 | 222.8 | 173.3 | 248.3 | 221.1 | Upgrade
|
| Total Revenue | 8,770 | 8,556 | 8,030 | 7,398 | 7,105 | 7,032 | Upgrade
|
| Revenue Growth (YoY) | 5.22% | 6.56% | 8.53% | 4.13% | 1.03% | 3.73% | Upgrade
|
| Policy Benefits | 6,843 | 6,655 | 6,289 | 6,057 | 5,680 | 5,558 | Upgrade
|
| Depreciation & Amortization | - | - | - | - | 115 | 122 | Upgrade
|
| Selling, General & Administrative | 674.4 | 656.6 | 619.5 | 566.6 | 290.4 | 281.5 | Upgrade
|
| Other Operating Expenses | 547.9 | 494.2 | 396.7 | 333.5 | - | - | Upgrade
|
| Total Operating Expenses | 8,065 | 7,806 | 7,306 | 6,957 | 6,547 | 6,396 | Upgrade
|
| Operating Income | 704.9 | 750.8 | 724.2 | 441.1 | 557.9 | 636.1 | Upgrade
|
| Interest Expense | -11.7 | -11 | -5.4 | -1.8 | -2.4 | -2.8 | Upgrade
|
| Earnings From Equity Investments | -12.8 | -11 | -7.1 | -1.4 | 4.5 | -1 | Upgrade
|
| EBT Excluding Unusual Items | 680.4 | 728.8 | 711.7 | 437.9 | 560 | 632.3 | Upgrade
|
| Pretax Income | 680.4 | 728.8 | 711.7 | 437.9 | 560 | 632.3 | Upgrade
|
| Income Tax Expense | 208.1 | 219.5 | 215.3 | 129.3 | 166.1 | 191.1 | Upgrade
|
| Earnings From Continuing Ops. | 472.3 | 509.3 | 496.4 | 308.6 | 393.9 | 441.2 | Upgrade
|
| Net Income to Company | 472.3 | 509.3 | 496.4 | 308.6 | 393.9 | 441.2 | Upgrade
|
| Minority Interest in Earnings | -8.9 | -8.5 | -3.9 | - | - | - | Upgrade
|
| Net Income | 463.4 | 500.8 | 492.5 | 308.6 | 393.9 | 441.2 | Upgrade
|
| Net Income to Common | 463.4 | 500.8 | 492.5 | 308.6 | 393.9 | 441.2 | Upgrade
|
| Net Income Growth | -5.35% | 1.69% | 59.59% | -21.65% | -10.72% | 40.06% | Upgrade
|
| Shares Outstanding (Basic) | 2,759 | 2,754 | 2,754 | 2,754 | 2,754 | 2,754 | Upgrade
|
| Shares Outstanding (Diluted) | 2,759 | 2,754 | 2,754 | 2,754 | 2,754 | 2,754 | Upgrade
|
| EPS (Basic) | 0.17 | 0.18 | 0.18 | 0.11 | 0.14 | 0.16 | Upgrade
|
| EPS (Diluted) | 0.17 | 0.18 | 0.18 | 0.11 | 0.14 | 0.16 | Upgrade
|
| EPS Growth | -5.53% | 1.69% | 59.59% | -21.65% | -10.72% | 40.06% | Upgrade
|
| Free Cash Flow | 286 | 369.7 | 861.5 | 176.7 | 941.5 | 471.3 | Upgrade
|
| Free Cash Flow Per Share | 0.10 | 0.13 | 0.31 | 0.06 | 0.34 | 0.17 | Upgrade
|
| Dividend Per Share | 0.185 | 0.180 | 0.166 | 0.146 | 0.134 | 0.127 | Upgrade
|
| Dividend Growth | 7.56% | 8.43% | 13.70% | 8.96% | 5.51% | 5.83% | Upgrade
|
| Operating Margin | 8.04% | 8.77% | 9.02% | 5.96% | 7.85% | 9.05% | Upgrade
|
| Profit Margin | 5.28% | 5.85% | 6.13% | 4.17% | 5.54% | 6.27% | Upgrade
|
| Free Cash Flow Margin | 3.26% | 4.32% | 10.73% | 2.39% | 13.25% | 6.70% | Upgrade
|
| EBITDA | 722.2 | 768.6 | 738.1 | 454.2 | 571.2 | 654 | Upgrade
|
| EBITDA Margin | 8.24% | 8.98% | 9.19% | 6.14% | 8.04% | 9.30% | Upgrade
|
| D&A For EBITDA | 17.3 | 17.8 | 13.9 | 13.1 | 13.3 | 17.9 | Upgrade
|
| EBIT | 704.9 | 750.8 | 724.2 | 441.1 | 557.9 | 636.1 | Upgrade
|
| EBIT Margin | 8.04% | 8.77% | 9.02% | 5.96% | 7.85% | 9.05% | Upgrade
|
| Effective Tax Rate | 30.59% | 30.12% | 30.25% | 29.53% | 29.66% | 30.22% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.